Our CEO Paul Hudson reflects on our strong start of the year, driven by launches and the transformation of our portfolio of medicines and vaccines.

Learn more about our first quarter 2024 results: spkl.io/601542oaR

#SanofiResults $SAN $SNY

Our first quarter 2024 results are now available. Read the press release: sanofi.com/en/investors/f…

#SanofiResults  $SAN $SNY

Who inspires you to push the limits? For Youxin, senior scientist and volunteer for the #Olympic Games #Paris2024 , it’s her mentor Alexey. 💫 #IgnitingPotential #WeNeverSettle

#NEWS : Positive Phase 3 data demonstrate the potential of a new first-in-class treatment for immune thrombocytopenia ( #ITP ). Learn more about the results and how we’re committed to transforming the standard of care for people with ITP: sanofi.com/en/media-room/…

Sometimes we need someone who believes in us more than we believe in ourselves. 🔥

For #TeamSanofi athlete Ezra Frech, the person who ignites his potential 24/7 is his mum.

Find out more about his story 👇

#IgnitingPotential #Paris2024

NEWS: We chase the latest science to address unmet needs facing the #MultipleSclerosis community. Our new data at #AAN for our investigational anti-CD40L illustrates our progress. ⤵️ sanofi.com/en/media-room/…

We’re proud to announce that the #MeningitisFlag has received the #Impact2024 label from Paris 2024 💛💙💜

This label is all about reinforcing the important place that sport holds in society. Curious to read more? Check out below 👇

Meningitis Research COMOmeningitis

We’re one team working in relay for one purpose—every single day.

We chase the miracles of science to improve people’s lives.

Learn how we turn the impossible into possible: spkl.io/60134LAH7

#Sanofi #WeNeverSettle

We’re all in on AI. In a conversation with TED Talks, our CEO Paul Hudson shared it’s time for businesses to harness AI to achieve the extraordinary.

Watch to learn more: spkl.io/60184Loce

#RepsonsibleAI #Innovation #TEDTalks

We’re thrilled to announce that Sanofi has been named to Fast Company's Most Innovative Companies of 2024! Read more about this year’s #FCMostInnovative . ⬇️ spkl.io/60124LWcy

When scientists become... artists! 🔬🎨 Check out a special episode of our #NoJargon series where our scientists share their drawing skills.

Would you be up for more special episodes?

The countdown to the #Olympic and #Paralympic Games Paris 2024 continues! Watch the February Play It Back to catch up on our celebrations, and stay tuned for more next month 🏆

#IgnitingPotential

We’re presenting late-breaking data from our Phase 2b trial of a novel investigational anti-OX40-ligand medicine in atopic dermatitis at #AAD2024 . ⬇️

The women of Sanofi inspire us today and every day.

On this International Women's Day, Join us as we celebrate the journeys of four Sanofian women who chase the miracles of science to improve people's lives.

#IWD #InspireInclusion

Who ignites your potential? For Yul Moldauer OLY, #TeamSanofi artistic gymnast, his father has been there from the start, encouraging him to never settle.

Together, we can always push the limits of what's possible! That's why we believe in #IgnitingPotential
#Paris2024 Paris 2024

#DYK that multiple myeloma is the second most common blood cancer in the world? During #MyelomaActionMonth , we’re partnering with @imfmyeloma to amplify the voices of those living with multiple myeloma. Learn more: bit.ly/49Dr8wv

#NEWS : We’re presenting late-breaking Phase 2 data for a novel investigational oral BTK inhibitor in chronic spontaneous urticaria at  #AAAAI24 . Learn more: bit.ly/42SHqyX

Late-breaking Phase 4 data will be presented at #AAAAI24 . Explore the latest results in adults with uncontrolled moderate-to-severe asthma.
Learn more: bit.ly/49sru8Z

Our application for an investigational COPD medicine has been accepted by the U.S. FDA for priority review. Learn what this means for hundreds of thousands of patients in the U.S. living with this serious, progressive disease.

CC: Regeneron

Learn more ⬇️

We’re leveraging #AI to drive faster breakthroughs.

In FORTUNE, our CEO Paul Hudson covers how the technology could spark a new era of discovery and the challenges the industry must overcome to unlock its potential.

Read more: fortune.com/2024/02/19/san…